Deprescription: The prescription metabolism

ABSTRACT

Deprescribing is a structured approach to drug discontinuation. An alternative suggested term is “prescription metabolism.” The major aim of deprescription is to purge the drug(s) considered unwanted in a given patient, especially in the elderly patients with multiple comorbidities or in those suffering from chronic disease. Like drug metabolism, prescription metabolism is a way of eliminating unwanted, troublesome, or cost‑ineffective medications. The removal of such drugs has been found to decrease the incidence of adverse drug reactions and improves the rate of medication adherence, thereby reducing the economic burden on the patient as well as on the health care providers. Certain categories of drugs are to be tapered rather than abruptly stopped. Despite the availability of many tools to minimize drug therapy‑related problems, there is little guidance for the process of deprescribing in general clinical practice. Various methods to reduce the risks of polypharmacy include patient education, physician education, and regulatory intervention. The suggested S and S approach (seek and screen, save and severe, sensitize and supervise) may be tried for deprescribing in general practice. More research on deprescribing is the need of the hour in almost all branches of clinical medicine which may pave the way for the betterment of health care.

KEYWORDS

• Discontinuation
• pharmacolysis
• prescription pruning
• untrials
• withdrawal

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0976-500X.189680Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 7, ISSUE 3What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trialsRimplejeet Kaur, Preeti Sidhu, Surjit Singh · pp. 120–121Same type: Article
• Article · VOLUME 7, ISSUE 3Cold sodium chloride solution 0.9% and infrared thermography can be an alternative to radiopaque contrast agents in phlebographyAleksandr Livievich Urakov, Anton Aleksandrovic Kasatkin, Natalia Aleksandrovna Urakova, Tatiana Viktorovna Urakova · pp. 138–9Same type: Article
• Article · VOLUME 7, ISSUE 3Cisplatin resistance reversal by disulfiram and caffeineAshish R. Kadia, Gaurang B. Shah · pp. 139–141Same type: Article
• Article · VOLUME 7, ISSUE 3Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitisMahimanjan Saha, Surajit Gorai, Vaswatee Madhab · pp. 142–5Same type: Article